Taro CEO Kal Sundaram to return to Sun Pharma
Kal Sundaram will return to India to take up an executive position at Sun Pharma after the completion of his assignment at Taro Pharmaceuticals at the end of 201607-07-2016
07-07-2016
Buy Sun Pharma, target Rs 840: Ashish Kyal
Buy Sun Pharma with a target of Rs 840 and a stop loss of Rs 72001-07-2016
Updates on Buy back Offer
Vivro Financial Services Pvt Ltd ("Manager to the Buy back Offer") has submitted to BSE a Copy of Public Announcement ("PA") regarding buy back Offer pursuant to the provisions of Regulation 8(2) of SEBI (Buy-back of Securities) Regulation, 1998.28-06-2016
Why one should invest in Sun Pharma, UPL: Siddharth Sedani, Sharekhan
Why pharma and specialty chemical picks make sense for you28-06-2016
Buy back Offer
Sun Pharmaceutical Industries Ltd has submitted to BSE a copy of Public Announcement pursuant to the provisions of Regulation 8(2) of SEBI (Buy- back of Securities) Regualtion, 1998.27-06-2016
15 smart buy ideas from top global brokerage firms post Brexit-led fall
Deutsche Bank advises investors to look at sectors or stocks that are largely insulated from contagion risks. Among them are names like Sun Pharma, Lupin.27-06-2016
Sun Pharmaceutical Ind: The recovery phase
Merger hiccups with Ranbaxy and regulatory troubles will soon be resolved26-06-2016
Fixes Record Date for Buyback of equity shares
Sun Pharmaceutical Industries Ltd has informed BSE that the Company has fixed Record Date as July 15, 2016 for the purpose of Buyback of equity shares.24-06-2016
Sun Pharma Announces Buyback of Equity Shares
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated June 23, 2016 titled "Sun Pharma Announces Buyback of Equity Shares".24-06-2016
Board approves Buyback of equity shares
Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 23, 2016, inter alia, has approved the buyback by the Company of its fully paid up Equity Shares of face value of Re. 1/- (Rupee One only) each ("Equity Shares") not exceeding 75,00,000 (Seventy Five Lakhs) Equity Shares (representing up to 0.31% of the total paid-up Equity Share capital of the Company) at a price of Rs. 900/-...24-06-2016